Paul Sorajja

Paul Sorajja

Interventional cardiologist / Cardiologist
Abbott Northwestern Hospital - Minneapolis, United States of America

Latest contributions

Hotline - Mitral and tricuspid valvular interventions

16 Nov 2025 – From PCR London Valves 2025

This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...

Hotline - Valvular and structural interventions

16 Nov 2025 – From PCR London Valves 2025

This session presents pivotal advances in valvular and structural heart interventions, covering the SMART-MV trial on mitral valvotomy safety, outcomes of TAVR patients with tricuspid regurgitation undergoing TEER, and the application of the FLOWer embolic protection system across structural heart procedures. Additionally, it explores the impact...

Tendyne transcatheter mitral valve system in patients with severe mitral annular calcification: one-year outcomes from the SUMMIT Severe MAC cohort

27 Oct 2025

Luigi Biasco interviews Paul Sorajja about the SUMMIT MAC Pivotal Trial he presented at TCT 2025, in San Francisco.

Luigi Biasco

Author

Luigi Biasco

Author

Paul Sorajja

Indication and device selection for tricuspid interventions

09 Feb 2025 – From PCR Tokyo Valves 2025

Want to sharpen your skills in selecting the right patients and devices for transcatheter tricuspid interventions? Don’t miss this session!

Learn how to assess anatomical suitability for T-TEER and TTVR, identify patients who may benefit from replacement over repair and explore the latest insights on timing and...

Indication and device selection for tricuspid interventions

Future devices for structural heart interventions

08 Feb 2025 – From PCR Tokyo Valves 2025

Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.

Future devices for structural heart interventions

M-TEER for primary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...

M-TEER for primary mitral regurgitation

Maximising the potential of MitraClip in TEER therapy

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest advancements in TEER therapy with this PCR Tokyo Valves 2025 session dedicated to MitraClip. Through expert-led case discussions, gain a deeper understanding of complex scenarios, including restricted posterior leaflet in functional mitral regurgitation, commissure lesion (A3P3), and MitraClip combined with Amulet.

This session also...

Maximising the potential of MitraClip in TEER

Advanced imaging in tricuspid TEER - LIVE case

26 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:

  • A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Advanced imaging in tricuspid TEER - LIVE case

Featured Research - Mitral valve (Part 3)

25 Nov 2024 – From PCR London Valves 2024

Dive into the latest research on mitral valve interventions in this Featured Research - Mitral Valve (Part 3) session. Explore the impact of transmitral pressure gradient after transcatheter edge-to-edge repair in dialysis patients, a single-center experience with the novel Innovalve transfemoral mitral valve replacement system, the...

Featured Research - Mitral valve (Part 3)

Mitral and tricuspid hotline

16 May 2024 – From EuroPCR 2024

This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...

Mitral and tricuspid hotline

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

15 May 2024 – From EuroPCR 2024

Watch this session to gain insights into the clinical evidence of mitral TEER therapy for the Asian population, learn techniques for implanting a MitraClip in patients with challenging anatomy, and understand how to use the four clip sizes for optimal outcomes. The session also covers educational...

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

Mitral TEER challenges and complications

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, highlighting the challenges and complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Attendees will have the opportunity to engage in discussions and learn from the experiences shared by the presenters, covering...

Mitral TEER challenges and complications

Innovations in heart failure: moving the heart forward

13 May 2024 – From EuroPCR 2024

Innovations in heart failure: moving the heart forward

The TRILUMINATE pivotal trial: impact on practice and perspectives

19 Jul 2023

Watch the replay of this webinar with F. Praz, F. Maisano, V. Delgado, R. Hahn, M. Metra and P. Sorajja and learn about the latest randomised results on the treatment of tricuspid regurgitation and so much more!

Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)

18 May 2023 – From EuroPCR 2023

Based on an in-depth review of the data from TRILUMINATE pivotal, a randomized trial whose findings were recently published in the NEW ENGLAND JOURNAL of MEDICINE, this lecture explains how these results will impact clinical practice in the treatment of tricuspid regurgitation. Join the speakers and...

Emerging indications for TAVI

18 May 2023 – From EuroPCR 2023

Consult this session if you want to learn about emergent indications of transcatheter treatment of aortic valve disease, to appreciate current gaps in the evidence base and hear about upcoming clinical trials, and to highlight new technologies that will address these treatment gaps.

Emerging indications for TAVI

EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease

17 May 2023 – From EuroPCR 2023

The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral...

Innovations in tricuspid valve therapies and complication management

17 May 2023 – From EuroPCR 2023

Discover here the cutting-edge techniques and breakthroughs that are reshaping the field of tricuspid valve therapies, while learning the art of effectively managing complications.

Tricuspid valve therapies in interventional cardiology

Triluminate trial: how these data impact my practice

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben, discuss the results of the Triluminate trial with David Adams and Paul Sorajja. Together they comment on the take-home messages presented during the ACC.23/WCC scientific sessions and how this...

Triluminate trial: how these data impact my practice

Triluminate trial: deep dive into the outcomes

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben talk with David Adams and Paul Sorajja about the first landmark trial in the field of tricuspid valve disease, Triluminate. Together they discuss the results presented during the ACC.23/WCC...

Triluminate trial: deep dive into the outcomes

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art

Mitral annular calcification - From diagnosis to treatment

29 Nov 2022 – From PCR London Valves 2022

Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.

Mitral annular calcification - From diagnosis to treatment

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Transcatheter Mitral Valve therapy : repair or replace?

13 Dec 2021

Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.

Mitral replacement: expanding patient options, even mitral annular calcification!

18 May 2022 – From EUROPCR 2022

The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.

HighLife TSMVR study status and new developments

22 Nov 2021 – From PCR London Valves 2021

Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...

HighLife TSMVR study status and new developments

A heart-team discussion for tricuspid valve intervention

21 Nov 2021 – From PCR London Valves 2021

Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.

#2 - Transcatheter Mitral Valve therapy : repair or replace?

19 Oct 2021

Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.

Edge-to-edge mitral repair

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.

Edge-to-edge mitral repair

Innovations in surgical and transcatheter mitral valve intervention

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to hear more about the latest advances in surgical and transcatheter approaches to mitral valve disease and to appreciate the anatomical, clinical and engineering challenges associated with future development.

This session was originally presented during PCR Valves e-Course 2020.

Innovations in surgical and transcatheter mitral valve intervention